AAAAAA

   
Results: 1-17 |
Results: 17
DOSE-DENSE PACLITAXEL-CONTAINING ADJUVANT THERAPY FOR BREAST-CANCER
Authors: HUDIS CA
Citation: Ca. Hudis, DOSE-DENSE PACLITAXEL-CONTAINING ADJUVANT THERAPY FOR BREAST-CANCER, Oncology, 12(1), 1998, pp. 16-18
DOSE-DENSE THERAPY WITH WEEKLY 1-HOUR PACLITAXEL INFUSIONS IN THE TREATMENT OF METASTATIC BREAST-CANCER
Authors: SEIDMAN AD HUDIS CA ALBANEL J TONG W TEPLER I CURRIE V MOYNAHAN ME THEODOULOU M GOLLUB M BASELGA J NORTON L
Citation: Ad. Seidman et al., DOSE-DENSE THERAPY WITH WEEKLY 1-HOUR PACLITAXEL INFUSIONS IN THE TREATMENT OF METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3353-3361
DOSE-DENSE THERAPY WITH PACLITAXEL VIA WEEKLY 1-HOUR INFUSION - PRELIMINARY EXPERIENCE IN THE TREATMENT OF METASTATIC BREAST-CANCER
Authors: SEIDMAN AD HUDIS CA MCCAFFREY J TONG W CURRIE V MOYNAHAN ME THEODOULOU M TEPLER I GOLLUB M NORTON L
Citation: Ad. Seidman et al., DOSE-DENSE THERAPY WITH PACLITAXEL VIA WEEKLY 1-HOUR INFUSION - PRELIMINARY EXPERIENCE IN THE TREATMENT OF METASTATIC BREAST-CANCER, Seminars in oncology, 24(5), 1997, pp. 72-76
CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL - STILL THE GOLD STANDARD
Authors: HUDIS CA
Citation: Ca. Hudis, CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL - STILL THE GOLD STANDARD, Journal of clinical oncology, 14(7), 1996, pp. 1971-1973
PHASE-II STUDY OF WEEKLY INTRAVENOUS RECOMBINANT HUMANIZED ANTI-P185(HER2) MONOCLONAL-ANTIBODY IN PATIENTS WITH HER2 NEU-OVEREXPRESSING METASTATIC BREAST/
Authors: BASELGA J TRIPATHY D MENDELSOHN J BAUGHMAN S BENZ CC DANTIS L SKLARIN NT SEIDMAN AD HUDIS CA MOORE J ROSEN PP TWADDELL T HENDERSON IC NORTON L
Citation: J. Baselga et al., PHASE-II STUDY OF WEEKLY INTRAVENOUS RECOMBINANT HUMANIZED ANTI-P185(HER2) MONOCLONAL-ANTIBODY IN PATIENTS WITH HER2 NEU-OVEREXPRESSING METASTATIC BREAST/, Journal of clinical oncology, 14(3), 1996, pp. 737-744
PHASE-II AND PHARMACOLOGICAL STUDY OF DOCETAXEL AS INITIAL CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
Authors: HUDIS CA SEIDMAN AD CROWN JPA BALMACEDA C FREILICH R GILEWSKI TA HAKES TB CURRIE V LEBWOHL DE BASELGA J RAPTIS G GOLLUB M ROBLES M BRUNO R NORTON L
Citation: Ca. Hudis et al., PHASE-II AND PHARMACOLOGICAL STUDY OF DOCETAXEL AS INITIAL CHEMOTHERAPY FOR METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(1), 1996, pp. 58-65
ADJUVANT DRUG-THERAPY FOR OPERABLE BREAST-CANCER
Authors: HUDIS CA NORTON L
Citation: Ca. Hudis et L. Norton, ADJUVANT DRUG-THERAPY FOR OPERABLE BREAST-CANCER, Seminars in oncology, 23(4), 1996, pp. 475-493
SOURCES OF ANTICIPATORY EMOTIONAL DISTRESS IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER
Authors: DILORENZO TA JACOBSEN PB BOVBJERG DH CHANG H HUDIS CA SKLARIN NT NORTON L
Citation: Ta. Dilorenzo et al., SOURCES OF ANTICIPATORY EMOTIONAL DISTRESS IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER, Annals of oncology, 6(7), 1995, pp. 705-711
PACLITAXEL AS 2ND AND SUBSEQUENT THERAPY FOR METASTATIC BREAST-CANCER- ACTIVITY INDEPENDENT OF PRIOR ANTHRACYCLINE RESPONSE
Authors: SEIDMAN AD REICHMAN BS CROWN JPA YAO TJ CURRIE V HAKES TB HUDIS CA GILEWSKI TA BASELGA J FORSYTHE P LEPORE J MARKS L FAIN K SOUHRADA M ONETTO N ARBUCK S NORTON L
Citation: Ad. Seidman et al., PACLITAXEL AS 2ND AND SUBSEQUENT THERAPY FOR METASTATIC BREAST-CANCER- ACTIVITY INDEPENDENT OF PRIOR ANTHRACYCLINE RESPONSE, Journal of clinical oncology, 13(5), 1995, pp. 1152-1159
SEQUENTIAL ADJUVANT THERAPY WITH DOXORUBICIN PACLITAXEL/CYCLOPHOSPHAMIDE FOR RESECTABLE BREAST-CANCER INVOLVING 4 OR MORE AXILLARY NODES/
Authors: HUDIS CA SEIDMAN AD BASELGA J RAPTIS G LEBWOHL D GILEWSKI T CURRIE V MOYNAHAN ME SKLARIN N FENNELLY D UHLENHOPP M RIEDEL E YAO TJ NORTON L
Citation: Ca. Hudis et al., SEQUENTIAL ADJUVANT THERAPY WITH DOXORUBICIN PACLITAXEL/CYCLOPHOSPHAMIDE FOR RESECTABLE BREAST-CANCER INVOLVING 4 OR MORE AXILLARY NODES/, Seminars in oncology, 22(6), 1995, pp. 18-23
MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERIENCE WITH PACLITAXEL IN THE TREATMENT OF BREAST-CANCER
Authors: SEIDMAN AD HUDIS CA FENNELLY D RAPTIS G BASELGA J NORTON L
Citation: Ad. Seidman et al., MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERIENCE WITH PACLITAXEL IN THE TREATMENT OF BREAST-CANCER, Seminars in oncology, 22(5), 1995, pp. 108-116
MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERIENCE WITH PACLITAXEL IN THE TREATMENT OF BREAST-CANCER - FROM ADVANCED DISEASE TO ADJUVANT THERAPY
Authors: SEIDMAN AD HUDIS CA NORTON L
Citation: Ad. Seidman et al., MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERIENCE WITH PACLITAXEL IN THE TREATMENT OF BREAST-CANCER - FROM ADVANCED DISEASE TO ADJUVANT THERAPY, Seminars in oncology, 22(4), 1995, pp. 3-8
CONDITIONED EMOTIONAL DISTRESS IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER
Authors: JACOBSEN PB BOVBJERG DH SCHWARTZ MD HUDIS CA GILEWSKI TA NORTON L
Citation: Pb. Jacobsen et al., CONDITIONED EMOTIONAL DISTRESS IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER, Journal of consulting and clinical psychology, 63(1), 1995, pp. 104-114
DO WE NEED A STOPPING RULE FOR BREAST-CANCER
Authors: HUDIS CA
Citation: Ca. Hudis, DO WE NEED A STOPPING RULE FOR BREAST-CANCER, Cancer investigation, 12(5), 1994, pp. 543-544
TAXOL (PACLITAXEL) PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OF METASTATIC BREAST-CANCER
Authors: SEIDMAN AD NORTON L REICHMAN BS CROWN JPA YAO TJ HAKES TB LEBWOHL DE GILEWSKI TA HUDIS CA SURBONE A CURRIE V KLECKER R JAMISDOW C COLLINS J MARKS L QUINLIVAN S BERKERY R CANETTA R ONETTO N ARBUCK S
Citation: Ad. Seidman et al., TAXOL (PACLITAXEL) PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OF METASTATIC BREAST-CANCER, Oncology, 51, 1994, pp. 33-39
PACLITAXEL AND RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AS INITIAL CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
Authors: REICHMAN BS SEIDMAN AD CROWN JPA HEELAN R HAKES TB LEBWOHL DE GILEWSKI TA SURBONE A CURRIE V HUDIS CA YAO TJ KLECKER R JAMISDOW C COLLINS J QUINLIVAN S BERKERY R TOOMASI F CANETTA R FISHERMAN J ARBUCK S NORTON L
Citation: Bs. Reichman et al., PACLITAXEL AND RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AS INITIAL CHEMOTHERAPY FOR METASTATIC BREAST-CANCER, Journal of clinical oncology, 11(10), 1993, pp. 1943-1951
PRELIMINARY EXPERIENCE WITH PACLITAXEL (TAXOL(R)) PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OF BREAST-CANCER
Authors: SEIDMAN AD NORTON L REICHMAN BS CROWN JPA YAO TJ HEELAN R HAKES TB LEBWOHL DE GILEWSKI TA SURBONE A CURRIE V HUDIS CA KLECKER R JAMISDOW C COLLINS J QUINLIVAN S BERKERY R TOOMASI F CANETTA R FISHERMAN J ARBUCK S
Citation: Ad. Seidman et al., PRELIMINARY EXPERIENCE WITH PACLITAXEL (TAXOL(R)) PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OF BREAST-CANCER, Seminars in oncology, 20(4), 1993, pp. 40-45
Risultati: 1-17 |